Showing results (21-30 of 54) with videos related to
Sort By:
Pageof 6
Alimentary Pharmacology & Therapeutics|November 18, 2003
How patients manage gastrointestinal symptoms after pelvic radiotherapyB Gami, K Harrington, P Blake, et al.The British Journal of Radiology|March 8, 2014
Effect on therapeutic ratio of planning a boosted radiotherapy dose to the dominant intraprostatic tumour lesion within the prostate based on multifunctional MR parametersS F Riches, G S Payne, N M Desouza, et al.British Journal of Cancer|January 26, 2006
Feasibility of familial PSA screening: psychosocial issues and screening adherenceJ Sweetman, M Watson, A Norman, et al.British Journal of Cancer|November 1, 1996
Survival of patients with advanced urothelial cancer treated with cisplatin-based chemotherapyS D Fosså, C Sternberg, H I Scher, et al.British Journal of Cancer|January 26, 2006
The feasibility and results of a population-based approach to evaluating prostate-specific antigen screening for prostate cancer in men with a raised familial riskJ Melia, D Dearnaley, S Moss, et al.Cancer Treatment Reports|October 1, 1980
Danazol treatment of advanced breast cancerR C Coombes, D Dearnaley, J Humphreys, et al.British Journal of Cancer|May 20, 2004
Hormonal impact of the 17alpha-hydroxylase/C(17,20)-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancerA O'Donnell, I Judson, M Dowsett, et al.Alimentary Pharmacology & Therapeutics|March 5, 2008
Can biological markers act as non-invasive, sensitive indicators of radiation-induced effects in the gastrointestinal mucosa?L Wedlake, C McGough, C Hackett, et al.European Radiology|March 10, 2015
Multivariate modelling of prostate cancer combining magnetic resonance derived T2, diffusion, dynamic contrast-enhanced and spectroscopic parametersS F Riches, G S Payne, V A Morgan, et al.British Journal of Cancer|July 25, 2013
Randomised pilot study of dose escalation using conformal radiotherapy in prostate cancer: long-term follow-upA Creak, E Hall, A Horwich, et al.Pageof 6